Analysis of Research on Traditional Chinese Medicine in Lymphoma Treatment
DOI:
https://doi.org/10.54097/y3hg6s33Keywords:
Traditional Chinese Medicine (TCM); lymphoma; anti-cancer effect.Abstract
Although many studies indicate that the bioactive components of Traditional Chinese Medicine (TCM) possess anti-cancer properties, currently there is insufficient scientific evidence to substantiate TCM’s role in the treatment of lymphoma. This article analyzed relevant medical publications to explore the potential roles of TCM as a therapeutic solution for lymphoma to optimize patient outcomes. Certain TCM compound has been studied as a complementary treatment in reducing adverse effects of chemotherapy for lymphoma patients. Laboratory and animal studies have also explored how TCM compounds or formulas might have anti-cancer effect, including but not limited to, inducing apoptosis in lymphoma cells, inhibiting tumor proliferation, invasion and metastasis as well as modulating immune responses. However, most anti-tumor TCM monomers have not reached clinical research, resulting in limited proven evidence to substantiate their efficacy and safety in treating lymphoma. To address this, it is suggested that future research should prioritize the structural modification of active compounds, combination therapies, and comprehensive mechanistic studies to elucidate the underlying biological actions of TCM therapies. Additionally, large-scale, placebo-controlled clinical trials are necessitated to rigorously evaluate the efficacy and safety of TCM in lymphoma treatment and to minimize adverse effects or undesirable drug interactions.
Downloads
References
[1] Fang LH, Wang RP, Hu SY, Zhang L, Liu SL. Tounongsan extract induces apoptosis in cultured Raji cells. Chin J Integr Med., 2012, 18(7): 522–528.
[2] Zhang C, Cui GH, Liu F, Wu QL, Chen Y. Effects of triptolide on cell proliferation and CXCR4 expression in Burkitt’s lymphoma Raji cells in vitro. Chin J Cancer Res., 2007, 19(1): 27–31.
[3] Wang L, Zhang HJ, Chen BA, Xia G, Wang S, Cheng J, Shao Z, Gao C, Bao W, Tian L, et al. Effect of magnetic nanoparticles on apoptosis and cell cycle induced by wogonin in Raji cells. Int J Nanomedicine, 2012, 7: 789–798.
[4] Zhang W, Shi HF, Chen CM, Ren K, Xu YJ, Liu XY, He L. Curcumin enhances cisplatin sensitivity of human NSCLC cell lines through influencing Cu-Sp1-CTR1 regulatory loop. Phytomedicine, 2018, 48: 51–61.
[5] Mohapatra P, Satapathy SR, Siddharth S, Das D, Nayak A, Kundu CN. Resveratrol and curcumin synergistically induce apoptosis in cigarette smoke condensate transformed breast epithelial cells through a p21(Waf1/Cip1) mediated inhibition of Hh-Gli signaling. Int J Biochem Cell Biol., 2015, 66: 75–84.
[6] Xia C, Bai XP, Hou XY, Gou XL, Wang YT, Zeng H, Huang M, Jin J. Cryptotanshinone reverses cisplatin resistance of human lung carcinoma A549 cells through down-regulating Nrf2 pathway. Cell Physiol Biochem., 2015, 37(2): 816–824.
[7] Che JB, Liu ZH, Ma HB, Li Y, Zhao H, Li XH, Liu WC, Shi GN. Influence of As2O3 combined with ginsenosides Rg3 on inhibition of lung cancer NCI-H1299 cells and on subsistence of nude mice bearing hepatoma. Asian Pac J Trop Med., 2014, 7(10): 772–775.
[8] Zhang GF, Qin YM, Liu SB, Xi C, Zhang WW. Bibliometric analysis of research trends and topic areas in traditional Chinese medicine therapy for lymphoma. Pharmaceutical Biology, 2024, 62(1): 13–21.
[9] National Comprehensive Cancer Network, 2025, https://www.nccn.org/guidelines/category_1, 8 September 2025.
[10] Eyre TA, Cwynarski K, d'Amore F, et al. Lymphomas: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Annals of Oncology, 2025, 1: S0923-7534(25)00911-1.
[11] National Health Commission of the People’s Republic of China. National guidelines for diagnosis and treatment of malignant lymphoma 2022 in China. Chin J Cancer Res., 2022, 34(5):425–446.
[12] Jia R, Cao LP, Xu P, Jeney G, Yin GJ. In vitro and in vivo hepatoprotective and antioxidant effects of Astragalus polysaccharides against carbon tetrachloride-induced hepatocyte damage in common carp (Cyprinus carpio). Fish Physiol Biochem, 2012, 38(3): 871–81.
[13] Zhong RZ, Yu M, Liu HW, et al. Effects of dietary Astragalus polysaccharide and Astragalus membranaceus root supplementation on growth performance, rumen fermentation, immune responses, and antioxidant status of lambs. Anim Feed Sci Technol, 2012, 174: 60–7.
[14] Li XF, Guo X, Li J, Yuan L, Wang HX. Preventing effect of astragalus polysaccharide on cardiotoxicity induced by chemotherapy of epirubicin: A pilot study. Medicine (Baltimore), 2022, 101(32): e30000.
[15] Cancemi G, Caserta S, Gangemi S, Pioggia G, Allegra A. Exploring the Therapeutic Potential of Ganoderma lucidum in Cancer. Journal of Clinical Medicine, 2024, 13(4):1153.
[16] Ahmad MF. Ganoderma lucidum: A rational pharmacological approach to surmount cancer. J. Ethnopharmacol. 2020, 260: 113047.
[17] Wang XZ, Xia L, Zhang XY, Chen Q, Li X, Mou Y, Wang T, Y Zhang YN. The multifaceted mechanisms of Paeoniflorin in the treatment of tumors: State-of-the-Art. Biomedicine & Pharmacotherapy, 2022, 149: 112800.
[18] Huo XG, Hu XT, Chen LX, et al. Study on the stability of paeoniflorin. China Sci., 2017, 12(18): 2092-2097.
[19] Zhou AL, Zheng Y, Song Y, et al. Thermal stability of paeoniflorin in water extract and concentrated solution of Shujing Fangtong capsules. Chin. J. Exp. Tradit. Med. Formula, 2015, 21(07): 24-26.
[20] Li L, Jin XJ, Li JW, Li CH, Zhou SY, Li JJ, Feng CQ, Liu DL, Liu YQ. 2021. Systematic insight into the active constituents and mechanism of Guiqi Baizhu for the treatment of gastric cancer. Cancer Sci., 2021, 112(5):1772–1784.
[21] Lv D, Liu YL, Tang RY, Fu S, Kong SS, Liao Q, Li H, Lin LF. Analysis of Clinical Trials Using Anti-Tumor Traditional Chinese Medicine Monomers. Drug Des Devel Ther., 2024, 18:1997–2020.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Highlights in Science, Engineering and Technology
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
